Search Options Stock News and Analysis from Schaeffer's

Top- and Bottom-Line Beat Gives Regeneron Stock a Boost

https://www.schaeffersresearch.com/content/news/2022/02/04/top-and-bottom-line-beat-gives-regeneron-stock-a-boost

2/4/2022 10:26 AM

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) is up 1.9% to trade at $632.42 at last check, after the drug maker posted a top- and bottom-line beat for its fourth quarter, which included revenues nearly...

Biotech Stock Starts Rocky Month with Covid-19 Headwinds

https://www.schaeffersresearch.com/content/news/2021/12/01/biotech-stock-starts-rocky-month-with-covid-19-headwinds

12/1/2021 11:28 AM

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) has been in the spotlight this week, after the company's CEO Leonard Schleifer noted its Covid-19 antibody cocktail may be less effective against the omicro...

Regeneron Stock Slips Despite Earnings, Revenue Beat

https://www.schaeffersresearch.com/content/news/2021/11/04/regeneron-stock-slips-despite-earnings-revenue-beat

11/4/2021 10:33 AM

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) threw its hat into the earnings ring this morning, reporting third-quarter earnings and revenue that trounced Wall Street's estimates. The company also po...

Biotech Blasts to Record Highs After Upbeat Trial Data

https://www.schaeffersresearch.com/content/news/2021/06/28/biotech-blasts-to-record-highs-after-upbeat-trial-data

6/28/2021 10:43 AM

The shares of biotechnology name Intellia Therapeutics Inc (NASDAQ:NTLA) are soaring this morning, up 48% to trade at $131.92 at last check -- earlier hitting a record high of $144.39 -- after posit...

REGN Finds Redemption After Impressive Earnings Report

https://www.schaeffersresearch.com/content/news/2021/05/06/regn-finds-redemption-after-impressive-earnings-report

5/6/2021 10:40 AM

The shares of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) are rising on the company's upbeat first-quarter earnings report, which boasted a rise in profits to $9.89 per share -- toppling analysts' es...

PEOPLE ALSO SEARCH FOR